Hudson Bay Capital Management LP Avidity Biosciences, Inc. Transaction History
Hudson Bay Capital Management LP
- $25.3 Billion
- Q3 2025
A detailed history of Hudson Bay Capital Management LP transactions in Avidity Biosciences, Inc. stock. As of the latest transaction made, Hudson Bay Capital Management LP holds 30,000 shares of RNA stock, worth $2.12 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
30,000
Previous 30,000
-0.0%
Holding current value
$2.12 Million
Previous $1.31 Million
-0.0%
% of portfolio
0.01%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding RNA
# of Institutions
311Shares Held
139MCall Options Held
1.24MPut Options Held
526K-
Janus Henderson Group PLC London, X014.5MShares$1.03 Billion0.3% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.2MShares$936 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY11.4MShares$805 Million6.62% of portfolio
-
Wellington Management Group LLP Boston, MA10.1MShares$713 Million0.08% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD9.79MShares$693 Million0.05% of portfolio
About Avidity Biosciences, Inc.
- Ticker RNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,127,000
- Market Cap $3.69B
- Description
- Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic...